Thus, we checked the expression of p-SMAD3 in KRT19 knockdown colon and breast cancer cells, but there was no significant change observed upon KRT19 knockdown (Figure 4c), suggesting that β-catenin/SMAD3 mediated Wnt signaling activation was not involved in this phenomenon. The gene discussed is SMAD3; the disease is breast cancer.